UBS Downgrades Comerica to Neutral, Lowers Price Target to $59
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Erika Najarian downgraded Comerica (NYSE:CMA) from Buy to Neutral and reduced the price target from $66 to $59.

April 04, 2024 | 7:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
UBS analyst Erika Najarian downgraded Comerica from Buy to Neutral and lowered the price target from $66 to $59.
Analyst downgrades typically lead to a negative short-term impact on the stock price as they reflect a less optimistic view on the company's future performance. The reduction in the price target further emphasizes this negative outlook, suggesting that the stock may not achieve previously expected valuation levels in the near term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100